Population
Reticulocyte extracts and stably transfected HeLa cells
Design
Preclinical
Authors
Loading...
RLI modulation of RNase L may regulate IFN responses; leaves open its in vivo antiviral role pending further study.
The cloning and characterization of RLI identifies it as a novel endoribonuclease inhibitor that antagonizes the 2-5A/RNase L pathway and modulates interferon antiviral activity.
Bisbal et al. (1995) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: